Gabapentin
Product Images NDC 66116-444
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 66116-444). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Medvantx Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1. Weekly Mean Pain Score (observed Cases In Itt Population): Study 1 (6fa84b06 4292 43c2 888e 3e62b4c19a3d 02)
Figure 2. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 2 (6fa84b06 4292 43c2 888e 3e62b4c19a3d 03)
Figure 3. Proportion Of Responders (patients With > 50% Reduction In Pain Score) At Endpoint: Controlled Phn Studies (6fa84b06 4292 43c2 888e 3e62b4c19a3d 04)
Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients > 12 Years Of Age With Partial Seizures (6fa84b06 4292 43c2 888e 3e62b4c19a3d 05)
Gabapentin 300mg Capsules (6fa84b06 4292 43c2 888e 3e62b4c19a3d 06)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.